Background: There are no data on the prevalence of cytomegalovirus (CMV) shedding from a representative sample of the US population. This information is critical for understanding and preventing CMV. Methods: We tested urine specimens from CMV immunoglobulin (Ig) G-positive participants aged 6-49 years in 3 racial/ethnic groups from the National Health and Nutrition Examination Surveys 1999-2004 for the presence of CMV DNA using real-time polymerase chain reaction assay. We examined the association of sociodemographic characteristics with shedding prevalence and viral loads. Results: Among 6828 CMV IgG-positive participants tested, 537 had CMV DNA detected in urine-a shedding prevalence of 9.70%. Among persons aged 6-49 years, shedding prevalence was 3.83%. The prevalence of urinary shedding was inversely associated with increasing age (26.60%, 6.50%, and 3.45% in CMV IgG-positive participants aged 6-11, 12-19, and 20-49 years, respectively; P < .001 for trend test and pairwise comparisons). Urinary viral load also decreased significantly with age (mean, 2.97, 2.69, and 2.43 log10 copies/mL in those age groups, respectively; P < .001 for trend test and pairwise comparisons). Conclusions: Urinary CMV shedding and viral loads decreased dramatically with age, likely reflecting higher rates of primary CMV infection and longer duration of shedding in younger individuals. The findings demonstrate that children aged 6-11 years continue to shed CMV at higher rates and viral loads than adolescents and adults and thus may still be an important source for CMV transmission.
Background: There are no data on the prevalence of cytomegalovirus (CMV) shedding from a representative sample of the US population. This information is critical for understanding and preventing CMV. Methods: We tested urine specimens from CMV immunoglobulin (Ig) G-positive participants aged 6-49 years in 3 racial/ethnic groups from the National Health and Nutrition Examination Surveys 1999-2004 for the presence of CMV DNA using real-time polymerase chain reaction assay. We examined the association of sociodemographic characteristics with shedding prevalence and viral loads. Results: Among 6828 CMV IgG-positive participants tested, 537 had CMV DNA detected in urine-a shedding prevalence of 9.70%. Among persons aged 6-49 years, shedding prevalence was 3.83%. The prevalence of urinary shedding was inversely associated with increasing age (26.60%, 6.50%, and 3.45% in CMV IgG-positive participants aged 6-11, 12-19, and 20-49 years, respectively; P < .001 for trend test and pairwise comparisons). Urinary viral load also decreased significantly with age (mean, 2.97, 2.69, and 2.43 log10 copies/mL in those age groups, respectively; P < .001 for trend test and pairwise comparisons). Conclusions: Urinary CMV shedding and viral loads decreased dramatically with age, likely reflecting higher rates of primary CMV infection and longer duration of shedding in younger individuals. The findings demonstrate that children aged 6-11 years continue to shed CMV at higher rates and viral loads than adolescents and adults and thus may still be an important source for CMV transmission.
Authors: J Gunkel; T F W Wolfs; J Nijman; R Schuurman; M A Verboon-Maciolek; L S de Vries; J L Murk Journal: J Clin Virol Date: 2014-06-08 Impact factor: 3.168
Authors: Daniel E Noyola; Beatriz H Valdez-López; Alba E Hernández-Salinas; Miguel A Santos-Díaz; Miguel A Noyola-Frías; Juan F Reyes-Macías; Leticia G Martínez-Martínez Journal: Arch Med Res Date: 2005 Sep-Oct Impact factor: 2.235
Authors: J de F Correia-Silva; J M N Victória; A L S Guimarães; U E Salomão; M H N G de Abreu; H Bittencourt; R S Gomez Journal: Oral Dis Date: 2007-03 Impact factor: 3.511
Authors: Suchetha Murthy; Gary S Hayward; Sarah Wheelan; Michael S Forman; Jin-Hyun Ahn; Robert F Pass; Ravit Arav-Boger Journal: PLoS One Date: 2011-01-10 Impact factor: 3.240
Authors: Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar Journal: J Infect Dis Date: 2020-03-05 Impact factor: 5.226
Authors: Jodie L White; Eshan U Patel; Alison G Abraham; Mary Kate Grabowski; Ravit Arav-Boger; Robin K Avery; Thomas C Quinn; Aaron A R Tobian Journal: Open Forum Infect Dis Date: 2019-06-05 Impact factor: 3.835
Authors: Bryan T Mayer; Elizabeth M Krantz; Anna Wald; Lawrence Corey; Corey Casper; Soren Gantt; Joshua T Schiffer Journal: Viruses Date: 2020-02-03 Impact factor: 5.048
Authors: Christian Berg; Mette M Rosenkilde; Thomas Benfield; Lene Nielsen; Thomas Sundelin; Hans R Lüttichau Journal: BMC Infect Dis Date: 2021-04-26 Impact factor: 3.090
Authors: Jenna L Riis; Hedyeh Ahmadi; Olivia Silke; Steve W Granger; Crystal I Bryce; Douglas A Granger Journal: Front Immunol Date: 2020-08-28 Impact factor: 7.561